These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

462 related articles for article (PubMed ID: 8168083)

  • 21. Anti-vascular endothelial growth factor receptor 2 antibody reduces tumorigenicity and metastasis in orthotopic prostate cancer xenografts via induction of endothelial cell apoptosis and reduction of endothelial cell matrix metalloproteinase type 9 production.
    Sweeney P; Karashima T; Kim SJ; Kedar D; Mian B; Huang S; Baker C; Fan Z; Hicklin DJ; Pettaway CA; Dinney CP
    Clin Cancer Res; 2002 Aug; 8(8):2714-24. PubMed ID: 12171905
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of caspases by cytokine response modifier A blocks androgen ablation-mediated prostate cancer cell death in vivo.
    Srikanth S; Kraft AS
    Cancer Res; 1998 Feb; 58(4):834-9. PubMed ID: 9485043
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ectopical expression of human MUC18 increases metastasis of human prostate cancer cells.
    Wu GJ; Peng Q; Fu P; Wang SW; Chiang CF; Dillehay DL; Wu MW
    Gene; 2004 Mar; 327(2):201-13. PubMed ID: 14980717
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characterization of a novel androgen-sensitive, prostate-specific antigen-producing prostatic carcinoma xenograft: LuCaP 23.
    Ellis WJ; Vessella RL; Buhler KR; Bladou F; True LD; Bigler SA; Curtis D; Lange PH
    Clin Cancer Res; 1996 Jun; 2(6):1039-48. PubMed ID: 9816265
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comprehensive genotypic analysis of human prostate cancer cell lines and sublines derived from metastases after orthotopic implantation in nude mice.
    Lensch R; Götz C; Andres C; Bex A; Lehmann J; Zwergel T; Unteregger G; Kamradt J; Stoeckle M; Wullich B
    Int J Oncol; 2002 Oct; 21(4):695-706. PubMed ID: 12239607
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Stromal cells promote angiogenesis and growth of human prostate tumors in a differential reactive stroma (DRS) xenograft model.
    Tuxhorn JA; McAlhany SJ; Dang TD; Ayala GE; Rowley DR
    Cancer Res; 2002 Jun; 62(11):3298-307. PubMed ID: 12036948
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Androgen receptor-dependent regulation of Bcl-xL expression: Implication in prostate cancer progression.
    Sun A; Tang J; Hong Y; Song J; Terranova PF; Thrasher JB; Svojanovsky S; Wang HG; Li B
    Prostate; 2008 Mar; 68(4):453-61. PubMed ID: 18196538
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An in vivo model of prostate carcinoma growth and invasion in bone.
    Fisher JL; Schmitt JF; Howard ML; Mackie PS; Choong PF; Risbridger GP
    Cell Tissue Res; 2002 Mar; 307(3):337-45. PubMed ID: 11904770
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transfected neu oncogene induces human prostate cancer metastasis.
    Zhau HY; Zhou J; Symmans WF; Chen BQ; Chang SM; Sikes RA; Chung LW
    Prostate; 1996 Feb; 28(2):73-83. PubMed ID: 8604395
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Development of metastatic and non-metastatic tumor lines from a patient's prostate cancer specimen-identification of a small subpopulation with metastatic potential in the primary tumor.
    Lin D; Bayani J; Wang Y; Sadar MD; Yoshimoto M; Gout PW; Squire JA; Wang Y
    Prostate; 2010 Nov; 70(15):1636-44. PubMed ID: 20564316
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transdifferentiation of prostate cancer cells to a neuroendocrine cell phenotype in vitro and in vivo.
    Burchardt T; Burchardt M; Chen MW; Cao Y; de la Taille A; Shabsigh A; Hayek O; Dorai T; Buttyan R
    J Urol; 1999 Nov; 162(5):1800-5. PubMed ID: 10524938
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Butyrate analogue, isobutyramide, inhibits tumor growth and time to androgen-independent progression in the human prostate LNCaP tumor model.
    Gleave ME; Sato N; Sadar M; Yago V; Bruchovsky N; Sullivan L
    J Cell Biochem; 1998 Jun; 69(3):271-81. PubMed ID: 9581866
    [TBL] [Abstract][Full Text] [Related]  

  • 33. TabBO: a model reflecting common molecular features of androgen-independent prostate cancer.
    Navone NM; Rodriquez-Vargas MC; Benedict WF; Troncoso P; McDonnell TJ; Zhou JH; Luthra R; Logothetis CJ
    Clin Cancer Res; 2000 Mar; 6(3):1190-7. PubMed ID: 10741751
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Differential proteomic analysis and function study of human prostate carcinoma cells with different osseous metastatic tendency].
    Song DX; Chen AM; Guo FJ; Liao H; Xie BZ; Zhu B; Chen C
    Zhonghua Yi Xue Za Zhi; 2008 Apr; 88(17):1197-201. PubMed ID: 18844116
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Murine androgen-independent neuroendocrine carcinoma promotes metastasis of human prostate cancer cell line LNCaP.
    Uchida K; Masumori N; Takahashi A; Itoh N; Kato K; Matusik RJ; Tsukamoto T
    Prostate; 2006 Apr; 66(5):536-45. PubMed ID: 16372327
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Osteoprotegerin/osteoclastogenesis inhibitory factor decreases human prostate cancer burden in human adult bone implanted into nonobese diabetic/severe combined immunodeficient mice.
    Yonou H; Kanomata N; Goya M; Kamijo T; Yokose T; Hasebe T; Nagai K; Hatano T; Ogawa Y; Ochiai A
    Cancer Res; 2003 May; 63(9):2096-102. PubMed ID: 12727825
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transition of an androgen-dependent human prostate cancer cell line into an androgen-independent subline is associated with increased angiogenesis.
    Gustavsson H; Welén K; Damber JE
    Prostate; 2005 Mar; 62(4):364-73. PubMed ID: 15389782
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differential metastasis-associated gene analysis of prostate carcinoma cells derived from primary tumor and spontaneous lymphatic metastasis in nude mice with orthotopic implantation of PC-3M cells.
    Chu JH; Sun ZY; Meng XL; Wu JH; He GL; Liu GM; Jiang XR
    Cancer Lett; 2006 Feb; 233(1):79-88. PubMed ID: 15885894
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Smad3 is overexpressed in advanced human prostate cancer and necessary for progressive growth of prostate cancer cells in nude mice.
    Lu S; Lee J; Revelo M; Wang X; Lu S; Dong Z
    Clin Cancer Res; 2007 Oct; 13(19):5692-702. PubMed ID: 17908958
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Establishment of bone metastasis model of prostate cancer in nude mice by intratibia injection of human prostate cancer cell line Du145].
    Luo Y; Zhang LL; Ning L; He DL; Fan JH; Hou HL
    Zhonghua Nan Ke Xue; 2006 Feb; 12(2):133-6. PubMed ID: 16519149
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.